Michelle Aszterbaum
0000-0002-6126-7644
Publication & Citation Trends
Publications
0 total
Research Techniques Made Simple: Emerging Imaging Technologies for Noninvasive Optical Biopsy of Human Skin OA
Cited by 36
Semantic Scholar
Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Cited by 125
Semantic Scholar
Tazarotene: Randomized, Double-Blind, Vehicle-Controlled, and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome OA
Cited by 38
Semantic Scholar
Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. OA
Cited by 536
Semantic Scholar
Abstract LB-1: An investigator-initiated, phase II randomized, double-blind, placebo-controlled trial of GDC-0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) patients.gg
Cited by 13
Semantic Scholar
High prevalence of vitamin D deficiency in patients with basal cell nevus syndrome. OA
Cited by 33
Semantic Scholar
Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed
Cited by 3
Semantic Scholar
Research Topics
Hedgehog Signaling Pathway Studies
(21)
Genetic and rare skin diseases.
(9)
Cancer and Skin Lesions
(8)
Nonmelanoma Skin Cancer Studies
(6)
Inflammatory mediators and NSAID effects
(5)
Affiliations
San Francisco General Hospital
Kaiser Permanente
Cancer Research Institute
University of California, San Francisco
University of California, Irvine